Lisdexamfetamine OS is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older, and for the treatment of moderate to severe Binge Eating Disorder (BED) in adults.
Limitation of Use: Lisdexamfetamine OS is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Lisdexamfetamine OS for the treatment of obesity have not been established.
•ATC4: N06BA
• Strength: 10mg/ 1 ml (100 ml)
• Dosage form: Oral Solution
• Out-licensing is offered for all international markets
* Product availability is subject to patent restrictions in countries where applicable patents are in effect
